The 18th International Workshop on Chronic Lymphocytic Leukemia (iwCLL) is a biennial meeting taking place from 20 - 23 September in Edinburgh, Great Brittain. iwCLL is focused solely on advancing the understanding and treatment of chronic lymphocytic leukemia (CLL) and related lymphoproliferative disorders.
Founded in 1979, iwCLL is now the largest international meeting dedicated to advancing state-of-the-art and emerging concepts – from laboratory-based research to the clinic – in the pathobiology and treatment of these blood cancers. The biennial meeting is intended to provide a forum that promotes the exchange of information and encourages collaboration among international leaders and scientists interested in CLL and lymphoproliferative disorders in one location for four days every other year. The 2019 meeting will bring together a diverse selection of expert haematologists, clinicians, and researchers from around the world to discuss all aspects of CLL – from recent developments in the understanding of CLL biology, to innovations in diagnosis and prognosis, to strategies for treatment selection amidst a rapidly changing landscape, to recent clinical and real-world data with new and emerging agents.
For more information visit the iwCLl website > | For a direct link to the iwCLL program click here >
HARMONY Partner, Paolo Ghia from ERIC is speaking at iwCLL at 23 September 2019, at 15:30 hrs. He will give an update about the European Research Initiative on CLL (ERIC). ERIC is leading the HARMONY Research Project: Harnessing big data to predict prognosis in Chronic Lymphocytic Leukemia. Read more >
Receive the latest news. Click here to subscribe!
Public-private partnership for Big Data in Hematology
HARMONY and HARMONY PLUS are funded through the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients. Funding is received from the IMI 2 Joint Undertaking and is listed under grant agreement for HARMONY No. 116026 and grant agreement for HARMONY PLUS No. 945406. This Joint Undertaking receives support from the European Union’s Horizon 2020 Research and Innovation Programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA).
HARMONY Coordination Office
Institute of Biomedical Research of
Salamanca (IBSAL)
Salamanca, Spain
HARMONY Communications
European Hematology Association (EHA)
The Hague, The Netherlands
